Clinical trial
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly…
NCT00046891 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00046891 |
|---|---|
| Title | EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer |
| Official title | The Use of Ginkgo Biloba For The Prevention Of Chemotherapy-Related Cognitive Dysfunction |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Neurotoxicity |
| Intervention type | Drug, Other |
| Interventions | Ginkgo Biloba, Placebo |
| Enrollment | 226 |
| Start date | Dec 1, 2002 |
| Primary completion | Oct 1, 2006 |
| Completion | Apr 1, 2015 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: